The association between the presence of CD8+ T lymphocytes and survival of CRC patients was extracted from thirteen studies (Fig. 4) stratified by tumor location, with twelve evaluating the tumor center, five the stroma, and five the invasive margin. The gene discussed is CD8A; the disease is neoplasm.